Growth Metrics

RxSight (RXST) Gross Profit (2020 - 2026)

RxSight filings provide 6 years of Gross Profit readings, the most recent being $25.3 million for Q4 2025.

  • On a quarterly basis, Gross Profit fell 12.24% to $25.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $103.0 million, a 4.11% increase, with the full-year FY2025 number at $103.0 million, up 4.11% from a year prior.
  • Gross Profit hit $25.3 million in Q4 2025 for RxSight, up from $24.2 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $28.8 million in Q4 2024 to a low of -$812000.0 in Q2 2021.
  • Median Gross Profit over the past 5 years was $12.9 million (2023), compared with a mean of $14.1 million.
  • Biggest five-year swings in Gross Profit: tumbled 71.31% in 2021 and later skyrocketed 689.66% in 2022.
  • RxSight's Gross Profit stood at $2.9 million in 2021, then surged by 158.7% to $7.4 million in 2022, then soared by 137.86% to $17.7 million in 2023, then skyrocketed by 63.07% to $28.8 million in 2024, then fell by 12.24% to $25.3 million in 2025.
  • The last three reported values for Gross Profit were $25.3 million (Q4 2025), $24.2 million (Q3 2025), and $25.2 million (Q2 2025) per Business Quant data.